Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate nasal spray vs placebo in Chinese patients with allergic rhinitis
2015-004889-28Phase 3
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinitis (AR) and perennial rhinitis comparing Fluticasone furoate with Vehicle placebo (2 arms). Primary endpoint: Mean change from baseline in daily reflective total nasal symptom score (rTNSS).
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)perennial rhinitis
Beyond the preview
Go deeper on 2015-004889-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004889-28.